Jove
Visualize
Contact Us

Related Experiment Videos

Targeting cell death in dementia.

Paul Francis1

  • 1Wolfson Centre for Age-related Disorders, King's College London, London, UK. paul.francis@kcl.ac.uk

Alzheimer Disease and Associated Disorders
|June 15, 2006
PubMed
Summary

Alzheimer disease (AD) and vascular dementia (VaD) both involve neuronal degeneration. Despite different triggers, common downstream cell death pathways offer targets for neuroprotective agents in both neurodegenerative diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why diabetes matters in dementia studies: Excluding diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

A consensus privacy metrics framework for synthetic data.

Patterns (New York, N.Y.)·2025
Same author

Comparison of Three Anonymization Tools for a Health Fitness Study.

Scientific data·2025
Same author

Two-Eyed Seeing in action: Project extension for community health outcomes - Indigenous chronic pain & substance use.

Canadian journal of pain = Revue canadienne de la douleur·2025
Same author

Transcriptome-wide alternative splicing and transcript-level differential expression analysis of post-mortem Lewy body dementia brains.

Acta neuropsychiatrica·2025
Same author

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Health technology assessment (Winchester, England)·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neuroscience
  • Pathology
  • Neurology

Background:

  • Neuronal degeneration is central to Alzheimer disease (AD) and vascular dementia (VaD).
  • AD pathogenesis involves beta-amyloid and neurofibrillary tangles (NFTs).
  • VaD results from ischemic events (hemorrhage, hypoperfusion) causing oxygen and glucose deprivation.

Purpose of the Study:

  • To compare the neurodegenerative pathways in AD and VaD.
  • To identify common downstream mechanisms of cell death.
  • To explore potential therapeutic targets for neuroprotection.

Main Methods:

  • Comparative analysis of neurodegenerative processes in AD and VaD.
  • Identification of shared molecular pathways mediating neuronal cell death.
  • Review of potential intervention points for neuroprotective strategies.

Main Results:

  • AD and VaD exhibit distinct initial triggers and vulnerable neuronal populations.
  • Significant overlap exists in the downstream pathways leading to cell death.
  • Common cytotoxic pathways present multiple targets for neuroprotective agents.

Conclusions:

  • Despite differing etiologies, AD and VaD share common neurodegenerative pathways.
  • Targeting these shared pathways offers a promising strategy for developing neuroprotective therapies.
  • Further research into these common mechanisms could lead to effective treatments for both conditions.

Related Experiment Videos